tradingkey.logo
搜索

BioNexus Gene Lab Corp

BGLC
添加自选
2.030USD
+0.020+0.99%
收盘 07/02, 13:00美东报价延迟15分钟
4.91M总市值
亏损市盈率 TTM

BioNexus Gene Lab Corp

2.030
+0.020+0.99%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.99%

5天

-1.93%

1月

-11.55%

6月

-48.48%

今年开始到现在

-48.61%

1年

-68.43%

关键数据
2.050今开
2.050最高
2.85K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
0.12%换手率
2.000昨收
2.000最低
4.77K成交额
亏损市盈率静
0.61市净率
0.00%股息率 TTM
-31.37%ROA
15.60052周最高
1.33量比
-1.60M净利润
2.42M总股本
-1.4855每股收益TTM
2.20Beta
-36.62%ROE
1.92052周最低
2.50%振幅
-3.46%毛利率
4.91M总市值
-2.42回报/风险
5.30%风险率

TradingKey BioNexus Gene Lab Corp股票评分

单位: USD 更新时间: 2026-07-02

操作建议

BioNexus Gene Lab Corp当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在生物技术与医疗研究行业排名230/387位。机构持股占比非常高,中期看,股价处于下降通道。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

BioNexus Gene Lab Corp评分

相关信息

行业排名
230 / 387
全市场排名
477 / 4565
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

BioNexus Gene Lab Corp亮点

亮点风险
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
业绩增长期
公司处于发展阶段,最新年度总收入7.42M美元
估值高估
公司最新PE估值-1.37,处于3年历史高位
机构加仓
最新机构持股50.43K股,环比增加16.55%

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间

BioNexus Gene Lab Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

BioNexus Gene Lab Corp简介

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
公司代码BGLC
公司BioNexus Gene Lab Corp
CEOTan (Lee Su-Leng)
网址https://www.bionexusgenelab.com/

常见问题

BioNexus Gene Lab Corp(BGLC)的当前股价是多少?

BioNexus Gene Lab Corp(BGLC)的当前股价是 2.03。

BioNexus Gene Lab Corp的股票代码是什么?

BioNexus Gene Lab Corp的股票代码是BGLC。

BioNexus Gene Lab Corp股票的52周最高点是多少?

BioNexus Gene Lab Corp股票的52周最高点是15.60。

BioNexus Gene Lab Corp股票的52周最低点是多少?

BioNexus Gene Lab Corp股票的52周最低点是1.92。

BioNexus Gene Lab Corp的市值是多少?

BioNexus Gene Lab Corp的市值是4.91M。

BioNexus Gene Lab Corp(BGLC)股票的每股收益(EPS TTM)是多少

BioNexus Gene Lab Corp(BGLC)股票的每股收益(EPS TTM)是-1.61。